Growth Metrics

Gilead Sciences (GILD) Total Non-Current Liabilities (2016 - 2025)

Gilead Sciences' Total Non-Current Liabilities history spans 17 years, with the latest figure at $35.2 billion for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities fell 8.38% year-over-year to $35.2 billion; the TTM value through Dec 2025 reached $35.2 billion, down 8.38%, while the annual FY2025 figure was $35.2 billion, 8.38% down from the prior year.
  • Total Non-Current Liabilities reached $35.2 billion in Q4 2025 per GILD's latest filing, down from $36.2 billion in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $48.2 billion in Q1 2021 to a low of $34.6 billion in Q2 2024.
  • Average Total Non-Current Liabilities over 5 years is $38.8 billion, with a median of $38.1 billion recorded in 2022.
  • Peak YoY movement for Total Non-Current Liabilities: surged 50.74% in 2021, then decreased 16.0% in 2022.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $42.1 billion in 2021, then fell by 9.67% to $38.0 billion in 2022, then increased by 0.13% to $38.1 billion in 2023, then grew by 0.72% to $38.4 billion in 2024, then fell by 8.38% to $35.2 billion in 2025.
  • Per Business Quant, the three most recent readings for GILD's Total Non-Current Liabilities are $35.2 billion (Q4 2025), $36.2 billion (Q3 2025), and $35.3 billion (Q2 2025).